Diagnostik von Immundefekten

LaboratoriumsMedizin

Volumn 25, Issue 11-12, 2001, Pages 495-511

  Lehmann, Irina ^a   Borte, M ^b   Sack, U ^c  

^a HELMHOLTZ CENTRE FOR ENVIRONMENTAL RESEARCH UFZ   (Germany)

^b Universitätsklfnik und Polikiinik für Kinder und Jugendiiche   (Germany)

^c UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Durchflu zytome trie; flow cytometry; im munodiagnostics; Immundefekte; Immundiagnosiik; immunodeficiencies

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; IMMUNOGLOBULIN; OXYGEN RADICAL;

ANAMNESIS; ANTIBODY RESPONSE; CHEMOTAXIS; COMPLEMENT DEFICIENCY; CYTOKINE PRODUCTION; HEMOLYSIS; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNOGLOBULIN BLOOD LEVEL; INFECTION SENSITIVITY; LABORATORY DIAGNOSIS; PERIPHERAL LYMPHOCYTE; PERSISTENT INFECTION; PHAGOCYTOSIS; RECURRENT INFECTION; REVIEW; SERODIAGNOSIS; T LYMPHOCYTE SUBPOPULATION;

EID: 0035673990     PISSN: 03423026     EISSN: 14390477     Source Type: Journal    
DOI: 10.1515/labm.2001.25.11-12.495     Document Type: Article

References (204)

1. Smith, CI. Ochs, HD, Puck, JM. Genetically determined immunodeficiency diseases: a perspective. In: Smith C1, Ochs HD. Puck JM editors. Primary immunodeficiency diseases: A molecular and genetic approach. New York: Oxford University Press, 1999: 3-11.
2. Borle, M. Immunmangelkrankheiten. In: Baenkler HW, editor. Medizinische Immunologie. Grundlagcn, Klinik. Diagnostik, Therapie, Prophylaxe, Sonderbereiche. Landsberg/Lech: ecomed, 1999: 1–38.
3. Borle, M. Krause, GM. Vogimann, C. Braun, W. Phagocytic activities of neutrophils from healthy and high risk neonates-influence of intrauterine growth retardation. Immunobiology 1993:189:168-9.
4. Bone, M, Miler, I, Braun, W. Spencker, FB, Handrick, W, Vogtmann, C. Additive Therapie mit intravenösen Immunglobulinen bei neonataler E. coli-Sepsis. Padiatr Grenzgeb 1994;32:323-32.
5. Sorensen, RU, Moore, C. Antibodv deficiency syndromes. Pediatr Clin North Am 2000;47(6): 1225-52.
6. Borle, M, Schille, R, Hunkert, F. Braun, L, Handrick, W. Clinical relevance of IgG-subclasses in children with recurrent infections of the respiratory tract. Anliinf Drugs Chemother 1996;14:88–93.
7. Sack, U. Burkhardt, U. Bone, M, Schädlich, H, Berg, K, Emmrich, F,.Age-dependent levels of select immunological mediators in sera of healthy children. Clin Diagn Lab Immunol 1998;5(1):28–32.
8. Hulsiaeri, F, Hannet, I, Deneys, V. Munhyeshuli, V, Reichert, T, De, Bruyere M. Strauss, K. Age-related changes in Huitian blood lymphocyte subpopulations. II. Varying kinetics of percentage and absolute count measurements. Clin Immunol Immunopathol, 1994:70(2): 152-8.
9. Bruton, OC. Agammaglobulinemia. Pediatrics 1952;9:722-7.
10. Vetrie, D. Vorechovsky, I, Sideras, P, Holland, J, Davies, A, Flin-ler, F, Hammarstrom, L, Kinnon, C. Levinsky, R, Bobrow, M. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature 1993;361(6409): 226-33.
11. Tsukada, S, Saffran, DC, Ravlings, DJ, Parolini, O, Allen, RC, Klisak, I, Sparkes, RS. Kubagawa, H, Mohandas, T. Quan, S. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 1993;72(2):279-90.
12. Vihinen, M. BTKbasc: XLA-mutation resisiry. Immunol Today 1996;17(11):502-6.
13. Islam, TC. Smith, CI. The cellular phenotype conditions Btk for cell survival or apoptosis signaling. Immunol Rev 2000:178:49–63.
14. Conley, ME, Rohrer, J, Rapalus, L, Boylin, EC, Minegishi, Y. Defects in early B-cell development; comparing the consequences of abnormalities in pre-BCR signaling in the human and the mouse. Immunol Rev 2000:178:75–90.
15. Schifif, C, Lemmers, B, Devilie, A. Fougereau, M, Meffre, E. Autosomal primary immunodeficiencies affecting human bone marrow B-cell differentiation. Immunol Rev 2000;178:91-8.
16. Yel L, Minegishi, Y, Coustan-Smith, E, Buckley, RH, Trubel, H, Pachman, LM, Kitchingman, GR, Campana, D. Rohrer, J, Conley, ME, Mutations in the mu heavy-chain gene in patients with agammaglobulinemia. N Engl J Med 1996;335(20): 1486-93.
17. Minegishi, Y, Hendershoi, LM, Conley, ME. Novel mechanisms control the folding and assembly of lambda5/14.1 and VpreB to produce an intact surrogate light chain. Proc Natl Acad Sci U.S.A 1999;96(6):3041-6.
18. Minegishi Y. Cousian-Smith, E, Wang, YH, Cooper, MD, Campana, D, Conley, ME. Mutations in the human lambda5/14.1 gene result in B cell deficiency and agammaglobulinemia. J Exp Med 1998;187(1):71-7.
19. Hoffman, HM. Bastian, JF. Bird, LM. Humoral immunodeficiency with facial dysmorphology and limb anomalies: a new syndrome. Clin Dysmorphol 2001:10(1): 1–8.
20. Braconier, JH. Nilsson, B, Oxelius, VA. Karup-Pedersen, F. Re-cunrent pneumococcal infections in a patient with lack of specific IgG and IgM pneumococcal antibodies and deficiency of serum IgA, IgG2 and IgG4. Scand J Infect Dis 1984:16(4):407-10.
21. Plebani, A, Ugazio, AC. Meini, A. Ruggeri, L, Negrini, A, Alber-tini, A, Leibovitz, M, Duse, M, Bottaro, A, Brusco, R. Extensive deletion of immunoglobulin heavy chain constant region genes in the absence of recurrent infections; when is IgG subclass deficiency ciinicaliy relevant?. Clin Immunol Immunopathol 1993:68(1): 46–50.
22. Lawton, AR. IgG subclass deficiency and the day-care generation. Pediatr Infect Dis J 1999:18(5):462-6.
23. Soderstrom, C, Braconier, JH. Danielsson, D. Sjoholm, AG. Bactericidal activity for Neisseria meningitidis in properdin-deficient sera. J Infect Dis 1987:156(1): 107-12.
24. Pan, Q, Hammarstrom, L. Molecular basis of IgG subclass deficiency. Immunol Rev 2000;178:99–110.
25. Rockey JH. Hanson, LA, Heremans, JF. Kunkel, HG. Beta-2A agammaglobuMnemia in two healthy men. J Lab Clin Med
26. Rosen, FS, Kevy, SV, Merler, E. Janeway, CA, Gitlin, D. Recurrent bacterial infections and dysgammaglobulinemia: deficiency of 7S gamma-globulins in the presence of elevated 19S gamma-glo-bulins. Report of two cases. Pediatrics 1961;8:182-95.
27. Mayer, L. Kwan, SP, Thompson, C. Ko, HS. Chiorazzi, N. Waldmann, T, Rosen, F. Evidence for a defect in,.switch“ T cells in patients with immunodeficiency and hvperimmunoglobulinemia M. N Engl J Med 1986;314(7):409-13.
28. Notarangelo, LD, Peitsch, MC. CD401base: a database of CD40L gene mutations causing X-linked hyper-IçM.syndrome Immunol Today 1996; 17(11);511-6.
29. Revy, P, Muto, T, Levy, Y, Geissmann, F, Plebani, A, Sanal, O. Catalan, N, Forveille, M, Dufourcq-Labelouse, R, Gennery, A, Tezcan, I. Ersoy, F. Kayserili, H. Ugazio, AG, Brousse, N, Muramatsu, M, Notarangelo, LD, Kinoshita, K, Honjo, T, Fischer, A, Durandy, A. Activation-induced cytidine deaminase AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndromeHIGM2). Cell 2000;102(5):565-75.
30. Rump, JA, Jahreis, A. Schlesier, M, Drager, R. Melchers, I, Peter, HH. Possible role of IL-2 deficiency for hypogammaglobulinaemia in patients with common variable immunodeficiency. Clin Exp Immunol 1992;89(2):204-10.
31. Wijmenga, C, Hansen, RS, Gimelli, G, Bjorck, EJ, Davies, EG, Valentine, D. Belohradsky, BH, van, Dongen JJ, Smeets, DF, van, den Heuvel LP, Luyten, JA, Strengman, E, VVeemaes, C. Pearson, PL. Genetic variation in ICF svndrome: evidence for genetic heteroaenei-ty. Hum Mutat 2000; 16(6):509-17.
32. WHO scientific group. Primary immunodeficiency diseases. Clin Exp Immunol 1995:99:Suppl. 1.
33. Sorensen, RU, Leiva, LE, Giangrosso, PA, Butler, B. Javier, FC, III, Sacerdote, DM, Bradford, N, Moore, C. Response to a heptava-lent conjugate Streptococcus pneumoniae vaccine in children with recurrent infections who are unresponsive to the polysaccharide vaccine. Pediatr Infect Dis J 1998:17(8):685-91.
34. Gatti, RA, Berkel, I, Boder, E, Braedt, G, Charmley, R Concannon, P, Ersoy, F, Foroud, T, Jaspers, NG, Lange, K. Localization of an ata-xia-telangiectasia sene to chromosome 11q22-23. Nature 1988:336(6199):577-80.
35. DiGeorge, AM. Congenital absence of the thymus and its immunologic consequences: concurrence with congenital hypothy-reoidism. In: Bergsma.D., Good RA, editors. Birth defects: original article series. New York: March of Dimes-Binh Defects Foundation, 1968: 116-21.
36. Lodbell, DH. Cogsenital absence of the parathyroid glands. Arch Pathol 1959;67:412-8.
37. Cooper, MD, Peterson, RDA, Good, RA. A new concept of the cellular basis of immunity. J Pediatr 1965:67:907-8.
38. de, la CA, Herva, R, Koivisto, M, Aula, P. A deletion in chromosome 22 can cause DiGeorge svndrome. Hum Genet 1981;57(3):253-6.
39. Kornfeld, SJ, Zeffren, B. Christodoulou, CS, Day, NK, Cawkwell G, Good RA,. DiGeorge anomaly: A comparative study of the clinical and immunologic characteristics of patients positive and negative by fluorescence in situ hybridization. J Allergy Clin Immunol 2000;105(5):983-7.
40. Lamy, M., Nezelof, C. Thymus, hypoplasia in infants. Rev Fr Etud Clin Biol 1965;10(5):463-8.
41. Schuster, V., Kreth, HW,. X-linked lymphoproliferative disease is caused by deficiency of a novel SH2 domain-containing signal transduction adaptor protein. Immunol Rev 2000;178:21-8.
42. Coffey, AJ, Brooksbank, RA, Brandau, O., Oohashi, T., Howell, GR. Bye, JM, Cahn, AP. Durham, J., Heath, P., Wray, P., Paviit, R., Wilkinson, J., Leversha, M., Huckle, E., Shaw-Smith, CJ, Dunham, A., Rhodes, S., Schuster, V., Porta, G., Yin, L., Seraflni, P. Sylla, B. Zoilo, M., Franco, B., Bentley, DR. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-do-main encoding gene. Nat Genet 1998:20(2): 129-35.
43. Nichols, KE, Harkin, DP, Levitz, S. Krainer, M., Kolquist, KA, Genovese, C., Bernard, A., Ferguson, M., Zuo, L., Snyder, E., Buckler, A.J., Wise, C., Ashley, J., Lovett, M., Valentine, MB. Look, AT, Gerald, W., Housman, DE, Haber, DA. Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc Natl Acad Sci U S A 1998:95(23): 13765-70.
44. Sayos, J., Wu, C., Morra, M., Wang, N., Zhang, X., Allen, D., van Schaik, S., Notarangelo, L., Geha, R., Roncarolo, MG, Octtgen, H., De Vries, JE, Aversa, G., Terhorst, C. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-reccptor SLAM. Nature 1998:395(6701):462-9.
45. Donhuijsen-Am, R. Abken, H., Bornkamm, G. Donhuijsen, K., Grosse-Wilde, H., Neumann-Haefelin, D., Westerhausen, M., Wiegand, H. Fatal Hodgkin and non-Hodgkin lymphoma associated with persistent Epstein-Barr virus in four brothers. Ann Intern Med 1988;109(12):946-52.
46. Schuster, V., Hellebrand, H., Borte, M., Sack, U., Schulte Overberg-Schmidt, U., Stmad, N., Gierich, J., Meindl, A. Persistent hypogammaglobulinemia following Epstein-Barr virus infection may be suggestive for X-linkes lymphoproliferative disease also in families where only one male member is affected. 2001 in press.
47. Yasuda, N., Lai, PK, Rogers, J., Purtlo, DT. Defective control of Epstein-Barr virus-infected B cell growth in patients with X-linked Iymphoproliferative disease. Clin Exp Immunol 1991:83(1): 10-6.
48. Schuster, V., Steppberger, K., Borte, M. Manifestations of X-linked lymphoproliferative disease without prior Epstein-Barr exposure. Blood 2001:98(6): 1986-7.
49. Wiskott, A. Famil,äirer,. anseborener Morbus Werlhofii? Monats-schr Kinderheilkd 1937;68:212-6.
50. Cooper, MD, Chae, HP, Lowman, JT, Krivit, VV, Good, RA. Wiskott-Aldrich syndrome. An immunologic deficiency disease involving the afferent limb of immunity. Am J Med 1968:44(4):499–513.
51. Blaese, RM, Strober, W., Brown, RS, Waldmann, TA. The Wis-kott-.Aldrich syndrome. A disorder with a possible defect in antigen processing or recognition. Lancet 1968; 1(7551): 1056-61.
52. Kwan, SP, Sandkuyl, LA, Blaese, M., Kunkel, LM. Bruns, G. Parmley, R. Skarshaug, S. Page, DC. Ott, J. Rosen, FS. Genetic mapping of the Wiskott-Aldrich syndrome with two highly-linked poly-moiphic DNA markers. Genomics 1988:3(1):39-3.
53. Oda, A., Ochs, HD. Wiskott,-Aldrich syndrome protein and platelets. Immunol Rev 2000;178:111-7.
54. Thrasher, AJ, Burns, S., Lorenzi, R., Jones, GE. The Wiskott-Aldrich syndrome: disordered actin dynamics in haematopoietic cells. Immunol Rev 2000:178:118-28.
55. Dupuis, S., Doffinger, R., Picard, C. Fieschi, C., Altare, F., Jouanguy, E. Abef, L. Casanova, JL. Human interferon-gamma-mediated immunity is a genetically controlled continuous trait that determines the outcome of mycobacterial invasion. Immunol Rev 2000:178:129-37.
56. Frucht, DM, Holland, SM. Defective, monocyte costimulation for IFN-gamma production in familial disseminated Mycobacterium avium complex infection: abnormal 1L-12 regulation. J Immunol 1996;157(1):411-6.
57. Jouanguy, E., Lamhamedi-Cherradi, S., Lammas, D. Dorman, SE. Fondaneche, MC, Dupuis, S. Doffinger, R., Altare, F., Girdlestone, J. Emile, JF. Ducoulombier, H., Edgar, D., Clarke, J., Oxelius, VA, Brai, M., Novelli, V., Heyne, K., Fischer, A., Holland, SM, Kumararatne, DS, Schreiber, RD. Casanova, JL. A human IFNGRl small deletion hotspot associated with dominant susceptibility to mvcobacterial infection. Nat Genet 1999:21(4):370-8.
58. Uzel, G. Holland, SM. Thl, T-cell and monocyte defects. Pediatr Clin North Am 2000:47(6): 1275-89.
59. Rosatelli, MC, Meloni, A., Meloni, A., Devoto, M., Cao, A. Scott, HS, Peterson, P., Heino, M., Krohn, KJ, Nagamine, K., Kudoh, J., Shimizu, N., Antonarakis, SE. A common mutation in Sardinian autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients. Hum Genet 1998;103(4):428-34.
60. Ryser, O., Morell, A., Hitzig, WH. Primary immunodeficiencies in Switzerland: first report of the national registry in adults and children. J Clin Immunol 1988;8(6):479-85.
61. Gennery, AR, Cant, AJ. Diagnosis, of severe combined immunodeficiency. J Clin Pathol 2001:54(3): 191-5.
62. Griscelli, C., Durandy, A., Virelizier, JL, Ballet, JJ, Daguillard, F. Selective defect of precursor T cells associated with apparently normal B lymphocytes in.severe combined immunodeficiency disease. J. Pediatr 1978,:93(3):404-11.
63. Puck, JM. Pepper, AE, Henthom, PS. Candoni, F., Isakov, J. Whit-wam, T., Conley, ME, Fischer, RE, Rosenblatt, HM, Small, TN. Buckley, RH. Mutation analysis of ÍL2RG in human X-linked severe combined immunodeficiency. Blood 1997:89(6): 1968-77.
64. Puck, JM, Nussbaum, RL, Smead, DL. Conley, ME. X-linked se vere combined immunodeficiency: localization within the region Xq13.1-q21.1 by linkage and deletion analysis. Am J Hum Genet 1989;44(5):724-30).
65. Leonard, WJ. The, molecular basis, of X-linked severe combined immunodeficiency: defective cytokine receptor signalinii. Annu Rev Med 1996;47:229-39.
66. Weinberg, K., Parkman, R. Severe, combined immunodeficiency due to a specific defect in the production of interieukin-2. N Enel J Med 1990:322(24): 1718-23.
67. Sugamura, K., Asao, H., Kondo, M., Tanaka, N., Ishii, N., Nakamura, M. Takeshita, T. The common gamma-chain for multiple cytokine receptors. Adv Immunol 1995:59:225-77.
68. Macchi, P., Villa, A., Giliani, S., Sacco, MG, Frattini, A., Porta, F. Ugazio, AG, Johnston, JA, Candotti, F., O'Shea, JJ. Mutations of Jak-3 gene in patients with autosomal severe combined immune defi-ciencySCID). Nature 1995; 377(6544);65-8.
69. Giblett, ER. Anderson, JE, Cohen, F., Pollara, B., Meuwissen, HJ, Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. Lancet 1972: 2(7786): 1067-9.
70. SenGupta, S., Petsche, D., Gelfand, EW, Chechik, BE. A flow cytometric method for the detection of adenosine deaminase in mononuclear cells. J Immunol Methods 1985: 80(2): 155-62.
71. Giblett, ER, Ammann, AJ. Wara, DW, Sandman, R. Diamond, LK. Nucleoside-phosphorylase deficiency in a child with severely defective T-cell immunity and normal B-cell immunitv. Lancet 1975: 1(7914): 1010-3.
72. Stephan, JL, VIekova, V., Le Deist, F. Blanche, S., Donadieu, J. Saint-Basile, G. Durandy, A., Griscelli, C., Fischer, A. Severe combined immunodeficiency: a retrospective single-center study of clinical presentation and outcome in 117 patients. J Pediatr 1993; 123(4):564-72.
73. Buckley, RH, Schiff, SE, Markeri, ML, Williams, LW, Harville, TO, Roberts, JL, Puck, JM. Human severe combined immunodetlciency: genetic, phenotypic, and functional diversity in one hundred eight infants. J Pediatr 1997:130(3):378-87.
74. Fischer, A., Landais, P. Friedrich, W., Gerritsen, B. Fasih, A., Porta, F., Vellodi, A. Benkerrou, M., Jais, JP. Cavazzana-Calvo, M. Bone marrow transplantationBMT) in Europe for primary immunodeficiencies other than severe combined immunodetlciency: a report from the European Group for BMT and the European Group for Immunodeficiency. Blood 1994: 83(4): 1149-54.
75. Emile, JF, Geissmann, F. Martin, OC, Radford-Weiss, I. Lepelle-tier, Y., Heymer, B., Espanol, T., de Santes, KB, Bertrand, Y., Brousse, N. Casanova, JL, Fischer, A. Langerhans cell deficiency in reticular dysgenesis. Blood 2000; 96(1):58–62.
76. Omenn, GS. Familial, reticuloendotheliosis with, eosinophilia. N Engl J Med 1965; 273:427-32.
77. Santagata, S. Villa, A. Sobacchi, C., Cortes, P., Vezzoni, P. The genetic and biochemical basis of Omenn svndrome. Immunol Rev 2000; 178:64–74.
78. Schwarz, K., Gauss, GH. Ludwig, L., Pannicke, U. Li, Z., Lindner, D., Friedrich, W., Seger, RA. Hansen-Hagge, TE, Desiderio, S. Lieber, MR, Bartram, CR. RAG mutations in human B cell-negative SCID. Science 1996;274(5284);97-9.
79. Saint-Basile, G., Le Deist, F., de Villartay, JP, Cerf-Bensussan, N., Journet, O. Brousse, N., Griscelli, C. Fischer, A. Restricted heterogeneity of T lymphocytes in combined immunodeficiency with hypereosinophiliaOmenn's syndrome). J Clin Invest 1991: 87(4): 1352-9.
80. Hitzig, WH, Biro, Z., Bosch, H. Huser, HJ. Agammaglobulinamie und Alymphozytose mit Schwund des lymphatischen Gewebes. Helv Paediatr Acta 1958;13:551-8.
81. Schwarz, K., Bartram, CR. V(D)J-recombination pathology. Adv Immunol 1996; 61:285–326.
82. Le Deist, F., Thoenes, G., Corado, J., Lisowska-Grospierre, B., Fischer, A. Immunodeficiency with low expression of the T cell receptor/CD3 complex. Effect on T lymphocyte activation. Eur J Immunol 1991; 21(7):1641-7.
83. Arnaiz-Villena, A., Timon, M. Corell, A., Perez-Aciego, P. Martin-Villa, JM, Regueiro, JR. Brief report: primary immunodeficiency caused by mutations in the gene encoding the CD3-gamma subunit of the T lymphocyte receptor. N Engl J Med 1992;327(8): 529-33.
84. Mazer, B. Harbeck, RJ, Franklin, R., Schwinzer, R., Kubo, R., Hayward, A., Gelfand, EW. Phenotypic features of selectivo T cell deficiency characterized by absence of CD8+ T lymphocytes and undetectable mRNA for ZAP-70 kinase. Clin Immunol Immunopathol 1997:84(2): 129-38.
85. Sloan-Lancaster, J. Presley, J. Ellenberg, J. Yamazaki, T. Lippin-coit-Schwartz, J. Samelson, LE. ZAP-70 association with T cell receptorzetatcrzela): fluorescence imaging, of dynamic, changes upon cellular stimulation, J Cell Biol 1998: 143(3):613-24.
86. Puel, A., Ziegler, SF, Buckley, RH, Leonard, WJ. Defective ILR expression in T(-)B(+)NK(+) severe combined immunodeficiency. Nat Genet 1998; 20(4):394-7.
87. Uribe, L. Weinberg, KI. X-linked SCID and other defects of cytokine pathways. Semin Hematol 1998: 35(4):299–309.
88. Pahwa, R., Chatila, T., Pahwa, S., Paradise, C. Day, NK. Geha, R., Schvyartz, SA. Slade, H., Oyaizu, N., Good, RA. Recombinant interleukin 2 therapy in severe combined immunodeficiency disease. Proc Natl Acad Sci USA 1989;86(13):5069-73.
89. Waldburger, JM, Ma sternak, K., Muhleihaler-iMottet, A. Villard, J., Peretti, M., Landmann, S., Reith, W. Lessons from the bare lymphocyte syndrome: molecular mechanisms regulating MHC class II expression. Immunol Rev 2000: 178:148-65.
90. Segal, BH, Holland, SM Primary, phaaocytic disorders of childhood. Pediatr Clin North Am 2000: 47(6): 1311-38.
91. Janeway, CA. Craig, J., Davidson, M. Downey, W. Gitlin, D., Sullivan, JC. Hypergammaglobulinemia associated with severe, recurrent and chronic non-specitlc infection. Am J Dis Child 1954:88:388-92.
92. Clark, RA, Malech, HL, Gallin, JI, Nunoi, H. Volpp, BD, Pearson, DW. Nauseef, WM, Cumutte, JT. Genetic variants of chronic granulomatous disease: prevalence of deficiencies of two cytosolic components of the NADPH oxida.se system. N Éníl J Med 1989:321(10):647-52.
93. Cross, AR. Noack, D., Rae, J., Cumutte, JT, Heyworth, PG. Hematologically important mutations: the autosomal recessive forms of chronic granulomatous diseasefirst update). Blood Cells Mol Dis 2000: 26(5):56l-5.
94. Smith, RM, Cumutte, JT. Molecular, basis of chronic uranuloma-tous disease. Blood 1991:77(4):67–86.
95. Rothe, G., Valet, G. Flow, cytometric a.ssays of oxidative burst activity in phagocytes. Methods Enzymol 1994: 233:539-48.
96. Rothe, G., Oser, A., Valet, G. Dihydrorhodamine 123: a new flow cytometric indicator for respiratory hurst activity in neutrophil granulocytes. Naturwissenschaften 1988; 75(7):354-5.
97. Emmendorffer, A. Nakamura, M., Rothe, G., Spiekermann, K. Loh-mann-Matthes, ML, Roesler, J. Evaluation of flow cytometric methods for diagnosis of chronic granulomatous disease variants under routine laboratory conditions. Cytometry 1994:18(3): 147-55.
98. Vowells, SJ, Sekhsaria, S., Malech, HL, Shalit, M. Fleisher, TA. Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes. J Immunol Methods 1995:178(1):89–97.
99. Walker, UA, Riecken, B., Herbst, EW. Wolff Vorbeck, G., Schlesier, M., Peter, HH. Reduced oxidative burst in a granulocyte subpopulation in a case of Sweet svndrome. Immun Infekt 1993:1: 29–31.
100. Etzioni, A. Frydman, M., Pollack, S. Avidor, I. Phillips, ML, Paulson, JC, Gershoni-Baruch, R. Brief report: recurrent severe infections caused bv a novel leukocyte adhesion deficiency. N Enal J Med 1992: 327(25): 1789-92.
101. Royer-Pokora, B. Kunkel, LM, Monaco, AP, Goff, SC, Newbur-Ger, PE, Baçhner, RL, Cole, FS, Cumutte, JT. Orkin, SH. Cloning the gene for an inherited human disorder-chronic granulomatous disease-on the basis of its chromosomal location. Nature 1986:322(6074):32-8.
102. Eizioni, A. Tonetti, M. Leukocyte, adhesion deficiency II-from A to almost Z. Immunol Rev 2000;178:138-47.
103. Seger, RA. Granulozyten,- und Makrophagendefekte,. In: Wahn U. Seger R. Wahn V, editors. Padiatrische Allergologie und Immunologie. München: Urban & Fischer, 1999: 490-8.
104. Kishimoto, TK, Lanson, RS, Corbi, AL, Dustin, ML, Staunton, DE, Springer, TA. The leukocvte, intesrins. Adv Immunol 1989:46:149-82.
105. Wardlaw, AJ. Hibbs, ML, Stacker, SA, Springer, TA. Distinct mutations in two patients with leukocyte adhesion deficiency and ihcir functional correlates. J Exp Med 1990: 172(1):335-45.
106. Becker, R., Ptluger, KH. Myeloperoxidase deficiency: an epidemiological study and llow-cyiometric detection of other granular enzymes in myelopcroxidase-dellcieni subjects. Ann Hematol 1994: 69(4): 199–203.
107. Horwitz, M. Benson, KF, Person, RE, Aprikyan, AG, Dale, PC. Mutations in ELA2. encoding neutrophil elastase. define a 21-day biological clock in cyclic haematopoiesis. Nat Genet 1999: 23(4):433-6.
108. Dong, F. Hoefsloot, LH, Schelen, AM. Broeders, CA, Meijer, Y., Veerman, AJ, Touw, IP. Lowenberg, B. Identification of a nonsense mutation in the granulocyte-colony-stimulating factor receptor in severe congenital neutropenia. Proc Natl Acad Sci USA 1994: 91(10):4480-4.
109. Dong, F., Dale, DC, Bonilla, MA, Freedman, M., Fasth, A., Neijens, HJ, Palmblad, J., Briars, GL, Carlsson, G. Veerman, AJ, Welte, K., Lowenberg, B., Touw, IP. Mutations in the granulocyte colony-stimulating factor receptor gene in patients with severe consienital neutropenia. Leukemia 1997; 11 (1): 120-5.
110. Dong, F., Brynes, RK. Tidow, N., Welte, K., Lowenberg, B., Touw, IP. Mutations in the gene for the granulocyte colony-stlmulatins-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia. N Enul J Med 1995: 333(8): 487-93.
111. Welte, K., Dale, D. Pathophysiology, and treatment of severe chronic neutropenia. Ann Hematol 1996: 72(4): 158-65.
112. Blume, RS, Wolff, SM. The Chediak-Higashi syndrome: studies in four patients and a review of the literature. MedicineBalti-more, 1972:51 (4):247-80.
113. Clark, RA, Kimball, HR, Defective, granulocyte chemotaxis in the Chediak-Higashi syndrome. J Clin Invest 1971:50(12):2645-52.
114. Root, RK, Rosenthal, AS, Balestra, DJ. Abnormal bactericidal, metabolic, and Ivsosomal functions of Chediak-Hiuashi Svndrome leukocytes. J Clin Invest 1972: 51(3):649-65.
115. Griscelli, C., Durandy, A. Guy-Grand, D., Daguillard, F. Herzog, C., Prunieras, M. A syndrome, associating partial albinism and immunodeficiency. Am J Med 1978; 65(4):691–702.
116. Gallin, JI. Neutrophil, specific granule, deficiency. Annu Rev Med 1985:36:263-74.
117. Yamanaka, R., Barlow, C. Lekstrom-Himes, J. Castilla, LH, Liu, PP. Eckhaus, M., Decker, T., Wynshaw-Boris, A., Xanlhopoulos, KG. Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT/enhancer bindini: protein cpsilon-dciicient mice. Proc Natl Acad Sci USA 1997:94(24): 13187-92.
118. Schille, R., Bone, M. Kraemer, D. Handrick, W. Klinische und immunologische Befunde bei einem Kind mit Hvper-liiE-Syndrom. Padiatr Praxis 1996: 50:410-16.
119. Grimbacher, B., Holland, SM. Gallin, JI, Greenberg, F., Hill, SC, Malech, HL, Miller, JA, O'Connell, AC. Puck, JM. Hyper-IgE syndrome with recurrent infections-an auto.somal dominant multisystem disorder. N Engl J Med 1999:340(9):692–702.
120. Erlewyn-Lajeunesse, MD. Hyperimmunoglobulin-E, syndrome with recurrent infection: a review of current opinion and treatment. Pediatr Allergy Immunol 2000: 11 (3): 133-41.
121. Klemperer, MR, Woodwonh, HC, Rosen, FS, Austen, KF. Hereditary deficiency of the second component of complementC'2) in man. J Clin Invest 1966: 45(6):880-90.
122. Alper, CA, Propp, RP, Klemperer, MR, Rosen, FS. Inherited deficiency of the third component of human complementC‘3). J Clin Invest 1969;48(3);553-57.
123. Hauptmann, G., Grosshans, E., Heid, E., Mayer, S. Basset, A. Acute lupus erythematosus with total ab.sence of the C4 fraction of complement. Nouv Pre.sse Med 1974: 3(14):881-2.
124. Schmidt, BZ, Colten, HR. Complement,: a critical test of its biological importance. Immunol Rev 2000: 178:166-76.
125. Frank, MM. Complement, deficiencies. Pediatr, Clin Nonh Am 2000: 47(6): 1339-54.
126. Rosen, FS, Charache, P., Pensky, J., Donaldson, V. Hereditary angioneurotic edema: two genetic variants. Science 1965: 148:957-8.
127. Landerman, NS, Webster, ME, Becker, EL. Ratcliffe, HE. Hereditary angioneurotic edema. II. Deficiency of inhibitor for serum globulin permeability factor and for plasma kallikrein. J Allergy 1962; 33:330-41.
128. Weisser, M., Bone, M. Das hereditiire Angioodem-seltene Differentialdiagnose des akuten Abdomens in der kinderchirurgischen Praxis. Kinder- und Jugendmedizin 2001: 1:17–20.
129. Clinical, Applications of, Cytometry. Clinical, Cytometry Society and Medical University of South Carolina 12th annual meeting. Cytometry 1997: 30(6):344-56.
130. Kutok, JL, Roma, AO, Lemire, SJ, Dorfman, DM. Four-color flow cytometric immunophenotypic determination of peripheral blood CD4+ T lymphocyte counts: a comparison of validity and cost-effectivene.ss with a two-color method. Am J Clin Pathol 1998; 110(4):465-70.
131. Taylor, JM. Fahey, JL, Detels, R. Giorgi, JV. CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: which to choose, and how, lo use. J Acquir immune Defic Syndr 1989; 2(2): 114-24.
132. Giorgi, JV, Detels, R. T-cell subset alterations in HIV-infected homosexual men: NIAID Multicentèr AIDS cohort study. Clin Immunol Immunopathol 1989: 52(1): 10-8.
133. Malavasi, R. Funaro, A., Roggero, S., Horenstein, A. Calosso, L. Mehta, K. Human CD38: a glycoprotein in search of a function. Immunol Today 1994; 15(3):95-7.
134. Liu, Z. Hultin, LE, Cumberland, WG, Hultin, P. Schmid, I., Matud, JL. Detels, R. Giorgi, JV. Elevated relative fluorescence intensity of CD38 antigen expression on CD8+ T cells is a marker of poor pro-snosis in HIV infection: results of 6 years of follow-up. Cytometrv 1996:26(1): 1–7.
135. Mliu, Z. Cumberland, WG. Hultin, LE, Prince, HE, Detels, R., Giorgi, JV. Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV di.sease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 16(2):83–92.
136. Brgisser, P., Hammann, C., Kaufmann, D. Battegay, M. Rutsch-mann, OT. Expression of CD28 and CD38 by CD8+ T lymphocytes in HIV-1 infection correlates with markers of disease.severity and changes towards normalization under treatment. The Swiss HIV Cohort Study. Clin Exp Immunol 1999; 115(3):458-63.
137. Mocroft, A. Bofill, M., Lipman, M., Medina, E. Borthwick, N. Timms, A. Batista, L., Winter, M., Sabin, CA, Johnson, M., Lee, CA. Phillips, A., Janossy, G. CD8+.CD38+ lymphocyte percent: a useful immunological marker for monitoring HIV-1-infected patients. J Acquir Immune Det1c Syndr Hum Retrovirol 1997; 14(2): 158-62.
138. Vigano, A., Saresella, M. Rusconi, S. Ferrante, P. Clerici, M. Expression of CD38 on CD8 T cells predicts maintenance of high vi-raemia in HAART-treated HIV-1-infected children. Highly active antiretroviral therapy. Lancet 1998; 352(9144); 1905-6
139. Hultin, LE, Matud, JL, Giorgi, JV. Quantitation of CD38 activation antigen expre.ssion on CD8+ T cells in HIV-1 infection using CD4 expre.ssion on CD4+ T lymphocytes as a biological calibrator. Cytometry 1998:33(2): 123-32.
140. Lenkei, R., Bratt, G., Holmberg, V., Muirhead, K., Sandstrom, E. Indicators of T-cell activation: correlation between quantitative CD38 expre.ssion and soluble CD8 levels in asymptomatic HIV+ individuals and healthv controls. Cytometrv 1998; 33(2):115-22.
141. Clerici, M. Shearer, GM. The Th1-Th2 hypothesis of HIV infection: new in sights. Immunol Today 1994; 15(12):575-81.
142. Clerici, M., Shearer, GM. A TH1-TH2 switch is a critical step in the etiolosy of HIV infection. Immunol Today 1993: 14(3): 107-11.
143. Bofill, M. Mocroft, A., Lipman, M., Medina, E., Borthwick, NJ. Sabin, CA. Timms, A., Winter, M., Baptista, L., Johnson, MA, Lee, CA. Phillips, AN, Janossv, G. Increased numbers of primed activated CD8+CD38+CD45RO+ T cells predict the decline of CD4+ T cells in HIV-1-infected patients. AIDS 1996: 10(8):827-34.
144. Benito, JM. Zabay, JM, Gil, J., Bermejo, M. Escudero, A., Sanchez, E., Femandez-Cruz, E. Quantitative alterations of the functionally distinet subsets of CD4 and CDS T lymphocytes in asymptomatic HIV infection; changes in the expression of CD45RO. CD45RA. CDHb. CD38. HLA-DR, and CD25 anigens. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14(2): 128-35.
145. Mackall, CL. T-cell immunodeficiency, following cytotoxic antineoplastic therapy: a review. Oncologist 1999: 4(5):370-8.
146. Kootie, AM, Henny, FC, Tanke, HJ, Slats, J., van Es, LA, Paul, LC. Enumeration of Leu2a+, Leu2a+-DR+, and Leu2a+-Leul5+ cells in peripheral blood of renal transplant patients. Transplantation 1988: 45(1): 132-8.
147. Deng, MC, Breithardt, G., Scheld, HH. The Interdisciplinary Heart Failure and Transplant Program Mnster: a 5-year experience. ImJ Cardiol 1995; 50(1):7–17.
148. Raves, N., Bechstein, WO, Tullius, SG, Nussler, NC. Naumann, U. Jonas, S., Neuhaus, R., Serke, S. Neuhaus, P. Distribution of lymphocyte subtypes in liver transplant recipients with viral reinfection or de novo malignancy. Transplant Proc 1998; 30(5):l846-7.
149. Rayes, N. Bechstein, WO. Volk, HP, Tullius, SG, Nussler, N, Naumann, U. Jonas, S., Neuhaus, R., Serke, S., Neuhaus, P. Distribution of lymphocyte subtypes in liver transplant recipients. Transplant Proc 1997:29(1-2):501-2.
150. Laurcnii, L. Sica, S. Salutari, P. Rutella, S., Serafini, R., D'Onofrio, G. Rumi, C., Leone, G. Assessment of hematological and immunological, function during, long-term, follow-up after peripheral blood stem cell transplantation. Haematologica 1998; 83(2): 138-42.
151. Kusne, S., Dummer, JS, Singh, N., Iwatsuki, S., Makowka, L., Esquivel, C., Tzakis, AG, Starzl, TE, Ho, M. Infections after liver transplantation. An analysis of 101 consecutive cases. Medicinebaltimo-re, 1988:67(2): 132-43.
152. Rubin, RH. Infection, in organ, transplant recipients. In: Rubin RHYLS, editor. Clinical approach to infection in the compromised host. New York: Plenum, 1994: 629.
153. Kohlhaw, K., Schwarz, R., Lubke, P., Hartwig, T. Berr, F., Hauss, J. Clinical studies in liver transplantation. Chirurs 2000;71(6): 667-75.
154. Bock, HA. Gallati, H. Zurcher, RM. Bachofen, M., Mihatsch, MJ, Landmann, J., Thiel, G. A randomized prospective trial of prophylactic immunosuppression with ATG-fresenius versus OKT3 after renal transplantation. Transplantation 1995: 59(6):830-40.
155. Abouna, GM, Abdùllah, H., Kelly-Sullivan, D., Kumar, MS. Loose, J. Phillips, K., Yost, S. Seirka, D. Randomized clinical trial of antithymocyte globulin induction in renal transplantation comparing a fixed daily dose with dose adjustment according lo T cell monitoring. Transplantation 1995:59(11):l564-8.
156. Langrehr, JM, Nussler, NC, Neumann, U., Guckelberger, O. Loh-mann, R. Radtke, A., Jonas, S., Klupp, J. Steinmuller, T., Lobeck, H. Meuer, S., Schlag, H., Lemmens, HP. Knoop, M. Keck, H. Bechstein, WO, Neuhaus, P. A prospective randomized trial comparing interleukin-2 receptor antibody versus antithymocyte globulin as part of a quadruple immunosuppressive induction therapy following orthotopic liver transplantation. Transplantation 1997; 63(12):1772-81.
157. Goldfarb, NS, Avery, RK, Goormastic, M., Mehta, AC, Schilz, R., Smedira, N. Pien, L. Haug, MT. Gordon, SM, Hague, LK. Dresing, JM. Evans-Walker, T. Maurer, JR. Hypogammaglobulinemia in lung transplant recipients. Transplantation 2001: 71(2): 242-6.
158. Volk, HD, Reinke, P. Falck, P. Staffa, G., Briedigkeit, H. Von Bachr, R. Diagnostic value an immune monitoring program for the clinical management of immuno-suppressed patients with septic complications. Clin Transplant 1989: 3:246-52.
159. Docke, WD, Randow, F. Syrbe, U. Krausch, D., Asadullah, K. Reinke, P. Volk, HD, Kox, W. Monocyte deactivation in sepiic patients: restoration by IFN-uamma treatment. Nat Med 1997: 3(6): 678-81.
160. Kunz, D., Pross, M. Konig, W. Lippert, H. Manger, T. Diagnostic relevance of procalcitonin. lL-6 and cellular immune status in the early phase after liver transplantation. Transplant Proc 1998; 30(5):2398-9.
161. Burkhardt, U. Sack, U. Wild, L. Olthoff, D. Serum cytokines and cytokine receptors in children after small or larger surgical interventions with halothane anesthesia. Anaesthesiol Reanim 1997: 22(2):50-4.
162. Tarnok, A., Hambsch, J., Emmrich, F., Sack, U., van Son, J. Bel-linghausen, W. Borte, M. Schneider, P. Complement activation, cytokines, and adhesion molecules in children undergoing cardiac sur-sery with or without cardiopulmonary bypass. Pediatr Cardiol 1999; 20(2): 113-25.
163. Mackall, CL. T-cell immunodeficiency, following cytotoxic antineoplastic therapy: a review. Stem Cells 2000: 18(1): 10–18.
164. Chandra, RK. Nutrition, and the, immune system. Proc Nuir Soc 1993; 52(1):77–84.
165. Koletzko, B., Schroten, H. Ern,ährung und Immunfunktion. In: Wahn U, Seger R, Wahn V, editors. Pädoatri.sche Allergologie und Immunologie. Stuttgart, Jena. New York: Gu.stav Fischer, 1994: 95–101.
166. Myvrik, QN. Nutrition, and immunology. In: Shils ME, Young VY, editors. Modem Nutrition in Health and Disease. Philadelphia: Lea & Febiger, 1988: 585–616.
167. Tomkins, A. Hussey, G. Vitamin, A., immunity and infection. Nutr Res Rev 1989;2:17–28.
168. Keen, CL, Gershwin, ME. Zinc, deficiency and immune function. Annu Rev Nutr 1990;10:415-31.
169. van den Berk, JM. Oldenburger, RH. van den Berg, AP, Klomp-maker, IJ, Mesandcr, G., van Son, WJ, van der Bij, W., Sloof, MJ. The TH Low HLA-DR expression on monocytes as a prognostic marker for bacterial sepsis after liver transplantation. Transplantation 1997:63(12): 1846-8.
170. Volk, HD, Lohmann, T. Heym, S. Golosubow, A. Ruppe, U., Reinke, P., Thieme, M., Nieier, B., Tausch, W. Doecke, WD, Von Baehr, R. Decrease of the proportion of HLA-DR+ monocytes as prognostic parameters for the clinical outcome of septic disease. In: Masihi, KN, Lange, W, editors,. Immunotherapeutic prospects of infectious diseases. Berlin Heidelberg NewYork London Paris Tokyo HongKong Barcelona: Springer, 1990: 297–301.
171. Buchwaid, UK, Geerdes Fenge, HF, Vockler, J., Ziege, S., Lode, H. Interleukin-10: effects on phagocytosis and adhesion molecule expression of granulocytes and monocytes in a comparison with prednisolone. Eur J Med Res 1999: 4(3):85–94.
172. Gessler, P., Nebe, T., Birle, A., Haas, N., Kachel, W. Gessler, P., Nebe, T., Birle, A. Mueller, W., Kachel, W. Neutrophil respiratory burst in term and preterm neonates without signs of infection und in those with increased levels of C-reactive protein. Pediatr Res 1996: 39(5):843-8.
173. Bone, M., Miler, I. Braun, W. Phagocytosis of microspheric hydrophile panicles by peripheral blood glass-adherent phagocytes of healthy and high risk neonates. Acta Paediatr Hung 1989:29(1-2): 197–202.
174. Wahn, V. Seger, R. Diagnostisches Vorgehen bei Verdacht auf Abwehrschwache. In: Wahn U, Seger R. Wahn V editors. Padiatrische Allergologie und Immunologie. München. Jena: Urban und Fischer. 1999: 367-76.
175. Jung, T., Schauer, U., Heusser, C., Neumann, C. Rieger, C. Delection of intracellular cvtokines bv flow cvtometrv. J Immunol Methods 1993: 159(1-2): 197–207.
176. Peacock, JS, Colsky, AS, Pinto, VB. Lectins and antibodies as tools for studying cellular interactions. J Immiunol Methods 1990: 126(2): 147-57.
177. Maino, VC, Suni, MA. Ruitenberg, JJ. Rapid How cytometric method for measuring Ivmphocvte subset activation. Cvtometrv 1995: 20(2): 127-33
178. Hallden, G., Andensson, U. Hed, J. Johansson, SG. A new membrane permeabilization method for the detection of intracellular an-tiîien.s by How cvtometrv. J Immunol Methods 1989: 124(1):103-9.
179. Andersson, U. Hallden, G. Persson, U., Hed, J. Moller, G., DeLey, M. Enumeration of IFN-gamma-producing cclls by How cytomctry. Comparison with fluorescence microscopy. J Immunol Methods 1988: 112(1): 139-42.
180. Kabilan, L., Andersson, G. Lolli, F. Ekre, HP. Olsson, T. Troye-Blomberg, M. Detection of intracellular expression and secretion of interferon-gamma at the single-cell evel after activation of human T cells with tetanus toxoid in vitro. Eur J Immunol 1990: 20(5): 1085-9.
181. Schmitz, J., Assenmacher, M., Radbruch, A. Regulation of Thelper cell cytokine expression: functional dichotomy of antigen-presenting cells. Eur J Immunol 1993: 23(1): 1919.
182. Assenmacher, M., Schmitz, J. Radbruch, A. Flow cytometric determination of cytokines in activated murine T helper lymphocytes: expression of interleukin-10 in interferon-gamma and in interleukin-4-expressing cells. Eur J Immunol 1994: 24(5): 1097-101.
183. Vikingsson, A. Pederson, K., Muller, D. Enumeration of IFN-gamma producing lymphocytes by flow cytometry and correlation with quantitative measurement of IFN-gamma. J Immunol Methods 1994: 173(2):219-28.
184. Bussa, S. Rumi, C., Leone, G. Bizzi, B. Evaluation of a new whole blood cytometric lymphocyte transformation test for immunological screening. J Clin-Lab Immunol 1993: 40(1);39—46.
185. Mansour, I., Bourin, P. Rouger, P., Doinel, C. A rapid technique for lymphocyte preparation prior to two-color Immunohuore scence analysis of lymphocyte subsets using flow cytometry. Comparison with density sradient separation. J Immunol Methods 1990: 127(1):61–70.
186. Rabinovitch, PS. Kubbies, M., Chen, YC, Schindler, D., Hoehn, H. Brdu-Hoechst flow cvtometry: a unique tool for quantitative cell cycle analysis. Exp Cell Res 1988; 174(2):309-18.
187. Kaufman, SJ, Robert-Nicoud, M. DNA replication and differentiation in rat myobla.sts studied with monoclonal antibodies against, 5-bromodeoxyuridine, actin. and alpha 2-macroalobulin. Cytometry 1985: 6(6):570-7.
188. Rosenbloom, AJ, Pinsky, MR. Napolitano, C., Nguyen, TS, Le-vann, D., Pencosky, N., Dorrance, A., Ray, BK, Whiteside, T. Suppression of cytokine-mediated beta2-integrin activation on circulating neutrophils in critically ill patients. J Leukoc Biol 1999;66(1):83-9.
189. Engervall, P., Lundahl, J. Alterations in adhesion mole-culeCDll,b/CD18 and CD62L) expression on granulocytes after chemotherapy. Eur J Clin Invest 1998; 28(11):924-9.
190. Maekawa, K., Futami, S., Nishida, M., Terada, T., Inagawa, H., Suzuki, S., Ono, K. Effects of trauma and sepsis on soluble L-selectin and cell surface expression of L-selectin and CD I lb. J Trauma 1998:44(3):460-8.
191. Langermans, JA, Hazenbos, WL, van Funh, R. Antimicrobial functions of mononuclear phagocvtes. J Immunol Methods 1994: 174(1-2): 185-94.
192. Domachowske, JB, Malech, HL. Phagocytes. 1 ed. St. Louis: Mosby, 1996.
193. Hubei, K., Hegener, K. Schnell, R., Mansmann, G. Oberhauser, F., Staib, P. Diehl, V., Engert, A. Suppressed neutrophil function as a risk factor for severe infection after cytotoxic chemotherapy in patients with acute nonlymphocytic leukemia. Ann Hematol 1999: 78(2):
194. Bialek, R., Bartmann, P. Is there an effect of immunoglobulins and G-CSF on neutrophil phagocytic activity in preterm infants? Infection 1998: 26(6):375-8.
195. Shalekoff, S., Tiemessen, CT. Gray, CM, Martin, DJ. Depressed phagocytosis and oxidative burst in polymorphonuclear leukocytes from individuals with pulmonary tuberculosis with or without human immunodeficiency virus type 1 infection. Clin Diaun Lab Immunol 1998; 5(1):41-4.
196. Miyagawa, B. Klingemann, HG. Phagocytosis and burst activity of siranulocvtes and monocytes after stem cell transplantation. J Lab Clin Med 1997: 129(6):6V4-7.
197. Hoshino, T., Hara, A., Inouc, M. Honda, J. Imai, Y. Oiumi, K. Yo-koyama, MM. Flow cytometric measurement of NK cell cytotoxicity. J Clin Lab Immunol 1991: 36(1): 39–43.
198. Chang, L., Guscwitch, GA. Chrittoii, DB. Folz, JC. Lebeck, LK, Nehisen-Cannarella SL. Rapid flow cytometric a.ssay lor the assessment of natural killer cell activity. J Immunol Methods 1993: 166(1):45–54.
199. Lehmann, C., Glass, B., Zeis, M. Schmitz, N. Uharek, L. Investigating the lysis of small-cell lung cancer cell lines by activated natural Killernk, cells with a fluorometric assay for NK-cell-mediated cytotoxicity. Cancer Immunol Immunother 1999: 48(4): 209-13.
200. Goldberg, JE, Sherwood, SW, Clayberger, C. A novel method for measuring CTL and NK cell-mediated cytotoxicity using annexin V and two-color flow cytometry. J Immunol Methods 1999: 224(1-2): 1–9.
201. King, MA. Detection of dead cells and measurement of cell killin by flow cvtometry. J Immunol Methods 2000: 243(1-2): 155-66.
202. Sheehy, ME, McDermott, AB, Furlan, SN, Klenerman, P., Nixon, DF. A novel technique for the fluorometric assessment of Tlymphocyte antiüen specific Ivsis. J Immunol Methods 2001:249(1-2): 99–110.
203. Valiaho, J. Riikonen, P., Vihinen, M. Novel immunodeficiency data servers. Immunol Rev 2000: 178:177-85.
204. Vihinen, M., Arredondo-Vega, FX, Casanova, JL, Etzioni, A., Giliani, S., Hammarstrom, L., Hershfield, M.S., Heywonh, PG, Hsu, AP, Lahdesmaki, A. Lappalainen, I., Notarangelo, LD, Puck, JM. Reith, W., Roos, D., Schumacher, RF, Schwarz, K. Vezzoni, P. Villa, A., Valiaho, J., Smith, CI. Primary immunodeficiency mutation databases. Adv Genet 2001: 43:103-88.